Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Plos One
|
May 11, 2023
RWD-derived response in multiple myeloma
Tao Xu, James Roose, Mellissa Williamson, et al.
Japanese Journal of Clinical Oncology
|
March 13, 2021
Venetoclax in combination with azacitidine in Japanese patients with acute myeloid leukaemia: phase 1 trial findings
Shuichi Taniguchi, Takahiro Yamauchi, Ilseung Choi, et al.
Nature Medicine
|
January 20, 2015
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
Steven M Chan, Daniel Thomas, M Ryan Corces-Zimmerman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 13, 2022
Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study
Maria Lia Palomba, Guillaume Cartron, Leslie Popplewell, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 15, 2022
Combination of Atezolizumab and Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Results from a Phase 1b Study
M Lia Palomba, Brian G Till, Steven I Park, et al.
Leukemia Research
|
March 11, 2021
A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival
Jacqueline S Garcia, Ronan T Swords, Gail J Roboz, et al.
American Journal of Hematology
|
October 29, 2020
Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study
Daniel A Pollyea, Keith Pratz, Anthony Letai, et al.
Cell Stem Cell
|
November 27, 2015
Leukemia-Associated Cohesin Mutants Dominantly Enforce Stem Cell Programs and Impair Human Hematopoietic Progenitor Differentiation
Claire Mazumdar, Ying Shen, Seethu Xavy, et al.
Blood
|
October 27, 2018
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
Courtney D DiNardo, Keith Pratz, Vinod Pullarkat, et al.
Cell
|
March 3, 2015
Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands
Ignacio Moraga, Gerlinde Wernig, Stephan Wilmes, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Plos One
|
May 11, 2023
RWD-derived response in multiple myeloma
Tao Xu, James Roose, Mellissa Williamson, et al.
Japanese Journal of Clinical Oncology
|
March 13, 2021
Venetoclax in combination with azacitidine in Japanese patients with acute myeloid leukaemia: phase 1 trial findings
Shuichi Taniguchi, Takahiro Yamauchi, Ilseung Choi, et al.
Nature Medicine
|
January 20, 2015
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
Steven M Chan, Daniel Thomas, M Ryan Corces-Zimmerman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 13, 2022
Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study
Maria Lia Palomba, Guillaume Cartron, Leslie Popplewell, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 15, 2022
Combination of Atezolizumab and Obinutuzumab in Patients with Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: Results from a Phase 1b Study
M Lia Palomba, Brian G Till, Steven I Park, et al.
Leukemia Research
|
March 11, 2021
A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival
Jacqueline S Garcia, Ronan T Swords, Gail J Roboz, et al.
American Journal of Hematology
|
October 29, 2020
Venetoclax with azacitidine or decitabine in patients with newly diagnosed acute myeloid leukemia: Long term follow-up from a phase 1b study
Daniel A Pollyea, Keith Pratz, Anthony Letai, et al.
Cell Stem Cell
|
November 27, 2015
Leukemia-Associated Cohesin Mutants Dominantly Enforce Stem Cell Programs and Impair Human Hematopoietic Progenitor Differentiation
Claire Mazumdar, Ying Shen, Seethu Xavy, et al.
Blood
|
October 27, 2018
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
Courtney D DiNardo, Keith Pratz, Vinod Pullarkat, et al.
Cell
|
March 3, 2015
Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands
Ignacio Moraga, Gerlinde Wernig, Stephan Wilmes, et al.
Page
of 3